X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (128) 128
animals (74) 74
hematology (71) 71
male (64) 64
oncology (61) 61
female (58) 58
index medicus (53) 53
middle aged (46) 46
aged (39) 39
physics, applied (38) 38
gastroenterology & hepatology (37) 37
medicine, research & experimental (37) 37
adult (32) 32
materials science, ceramics (31) 31
biotechnology & applied microbiology (28) 28
genetics & heredity (27) 27
physics, condensed matter (26) 26
ceramics (23) 23
mice (23) 23
cancer (22) 22
chemistry, physical (21) 21
medicine & public health (20) 20
rats (19) 19
treatment outcome (19) 19
expression (17) 17
apoptosis (16) 16
electrical-properties (16) 16
research (16) 16
aged, 80 and over (15) 15
care and treatment (15) 15
cell line (15) 15
cell line, tumor (15) 15
ferroelectric properties (15) 15
analysis (14) 14
hot isostatic pressing (14) 14
cell biology (13) 13
chemotherapy (13) 13
in-vivo (13) 13
materials science, multidisciplinary (13) 13
progenitor cells (13) 13
therapy (13) 13
virology (13) 13
genetic aspects (12) 12
iron (12) 12
iron - metabolism (12) 12
medical colleges (12) 12
pharmacology & pharmacy (12) 12
thin film (12) 12
biochemistry & molecular biology (11) 11
cells, cultured (11) 11
figure of merit (11) 11
in-vitro (11) 11
polarization (11) 11
sputtering (11) 11
young adult (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
coculture techniques (10) 10
electrodes (10) 10
ferroelectrics (10) 10
gene expression (10) 10
growth (10) 10
growth-factor (10) 10
liver (10) 10
medicine, general & internal (10) 10
physics, multidisciplinary (10) 10
piezoelectric property (10) 10
pyroelectric property (10) 10
receptor (10) 10
solid oxide fuel cell (10) 10
time factors (10) 10
adenoviridae - genetics (9) 9
base sequence (9) 9
differentiation (9) 9
ferritin (9) 9
gene therapy (9) 9
health aspects (9) 9
immunohistochemistry (9) 9
infection (9) 9
infrared sensor (9) 9
measles virus - genetics (9) 9
measles virus - isolation & purification (9) 9
morphotropic phase boundary (9) 9
retrospective studies (9) 9
temperature (9) 9
cancer research (8) 8
cell differentiation (8) 8
cells (8) 8
chemistry (8) 8
deposition (8) 8
development and progression (8) 8
disease models, animal (8) 8
dose-response relationship, drug (8) 8
electrochemistry (8) 8
ferroelectric materials (8) 8
ferroelectricity (8) 8
gene (8) 8
japan (8) 8
la (8) 8
liver - metabolism (8) 8
marrow stromal cells (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 2, pp. 382 - 390
Journal Article
BLOOD, ISSN 0006-4971, 08/2004, Volume 104, Issue 4, pp. 1002 - 1009
Hematopoietic stem cells (HSCs) are a subset of bone marrow cells that are capable of self-renewal and of giving rise to all types of blood cells. However, the... 
EX-VIVO EXPANSION | PROGENITOR CELLS | CD34(+) CELLS | STEM-CELLS | MOBILIZED PERIPHERAL-BLOOD | SONIC HEDGEHOG | BONE-MARROW | MOUSE | CYCLE PROGRESSION | DIFFERENTIATION | HEMATOLOGY
Journal Article
Journal Article
by Tanaka, K and Arao, T and Tamura, D and Aomatsu, K and Furuta, K and Matsumoto, K and Kaneda, H and Kudo, K and Fujita, Y and Kimura, H and Yanagihara, K and Yamada, Y and Okamoto, I and Nakagawa, K and Nishio, K and Ooki, A and Yamashita, K and Yamaguchi, K and Asayama, M and Kadowaki, S and Hara, H and Yamada-murano, T and Arima, M and Tada, M and Watanabe, M and Yamashita-Kashima, Y and Shu, S and Yorozu, K and Iwai, T and Hashizume, K and Fujimoto-Ouchi, K and Harada, N and Tamaki, T and Shimizu, T and Katashiba, Y and Mikayama, H and Nomura, S and Kobayashi, N and Lim, H. Y and Kim, H and Park, C. K and Hour, T.- C and Wu, H.- L and Chuang, S.- J and Lu, C.- Y and Huang, C.- Y and Wu, W.- J and Pu, Y.- S and Wang, S.- W and Wu, H.- H and Wang, P.- C and Chou, W.- Y and Tang, C.- H and Tan, K.- L and Gan, S.- H and Hassan, R and Abdullah, A. D and Husin, A and Baba, A. A and Ankathil, R and Nagai, T and De Velasco, M. A and Sato, A and Nogami, N and Shinkai, T and Kozuki, T and Ogino, A and Misumi, Y and Hosomi, Y and Shimokawa, T and Hida, N and Seki, N and Honma, C and Okamoto, H and Shibuya, M and Morita, S and Watanabe, K and Terashima, T and Matsuzaki, T and Fujiwara, H and Nakaya, A and Ogawa, R and Naitou, A and Seki, Y and Kinoshita, A and Gouchi, M and Saito, Z and Yoshii, Y and Samejima, T and Seki, A and Kaneko, Y and Takeda, H and Kuwano, K and Sekihara, K and Okuma, Y and Takagi, Y and Iguchi, M and Okamura, T and Yoshino, R and Tomizawa, Y and ... and Korean Cancer Study Group(KCSG) and PRIAS-JAPAN Study Group
Annals of Oncology, ISSN 0923-7534, 10/2012, Volume 23, Issue suppl 11, pp. xi132 - xi167
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2012, Volume 23, Issue suppl 11, pp. xi99 - xi131
Journal Article
American Journal of Hematology, ISSN 0361-8609, 12/2017, Volume 92, Issue 12, pp. 1324 - 1332
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2013, Volume 71, Issue 3, pp. 789 - 797
The combination of docetaxel, cisplatin, and S-1 (DCS) chemotherapy is expected to be a promising regimen for advanced gastric cancer. This study was performed... 
Neoadjuvant chemotherapy | Medicine & Public Health | DSC | Oncology | Cancer Research | Advanced resectable gastric cancer | Nucleotide excision repair | Pharmacology/Toxicology | ADJUVANT CHEMOTHERAPY | SURGERY | PERIOPERATIVE CHEMOTHERAPY | GASTROESOPHAGEAL ADENOCARCINOMA | FLUOROURACIL | TRIAL | THERAPY | ONCOLOGY | ERCC1 | PHARMACOLOGY & PHARMACY | EXPRESSION | CARCINOMA | Endonucleases - genetics | Endosonography | Follow-Up Studies | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Antineoplastic Agents - administration & dosage | Endonucleases - metabolism | Antimetabolites, Antineoplastic - administration & dosage | Cisplatin - administration & dosage | DNA-Binding Proteins - metabolism | Antineoplastic Agents, Phytogenic - administration & dosage | Adult | Female | DNA Repair - drug effects | Drug Administration Schedule | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | Oxonic Acid - administration & dosage | Stomach Neoplasms - drug therapy | DNA-Binding Proteins - genetics | Taxoids - administration & dosage | Drug Resistance, Neoplasm - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Survival Analysis | Biomarkers | Tegafur - administration & dosage | Aged | Stomach Neoplasms - surgery | Drug Combinations | Immunohistochemistry | Antimitotic agents | Medical colleges | Chemotherapy | Nausea | Drug therapy, Combination | Antineoplastic agents | DNA repair | Stomach cancer | Cancer | Protein binding | Index Medicus | Dendritic cells | anorexia | Toxicity | DNA damage | Chemoresistance | Diarrhea | Disease control | Cisplatin | DNA-binding protein | Surgery | ERCC1 protein | Gastric cancer | Neutropenia | Tumors
Journal Article
Cancer Science, ISSN 1347-9032, 11/2018, Volume 109, Issue 11, pp. 3554 - 3563
Cisplatin plus 5‐fluorouracil is regarded as standard neoadjuvant chemotherapy for esophageal squamous cell carcinoma ( ESCC ) in Japan, but the prognosis... 
esophageal squamous cell carcinoma | neoadjuvant chemotherapy | esophageal cancer | docetaxel | nedaplatin | SURVIVAL | PROGNOSTIC-FACTORS | PATHOLOGICAL RESPONSE | LOCALLY ADVANCED ESOPHAGEAL | SURGICAL COMPLICATIONS | 5-FLUOROURACIL DCF | THERAPY | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | COMBINATION CHEMOTHERAPY | CISPLATIN PLUS FLUOROURACIL | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma, Squamous Cell - surgery | Male | Feasibility Studies | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Esophageal Neoplasms - surgery | Female | Neoadjuvant Therapy | Taxoids - adverse effects | Esophageal Squamous Cell Carcinoma | Drug Administration Schedule | Japan | Docetaxel | Esophagectomy | Treatment Outcome | Taxoids - administration & dosage | Carcinoma, Squamous Cell - drug therapy | Survival Analysis | Aged | Esophageal Neoplasms - drug therapy | Organoplatinum Compounds - adverse effects | Antimitotic agents | Squamous cell carcinoma | Oncology, Experimental | Adjuvant treatment | Clinical trials | Research | Antineoplastic agents | Esophageal cancer | Cancer | Thrombocytopenia | Lymphatic system | Leukopenia | Diarrhea | Cancer therapies | Patients | Cisplatin | Esophagus | Studies | Chemotherapy | Medical prognosis | Surgery | Response rates | Neutropenia | Pharmaceuticals | Original
Journal Article
Journal Article
Applied Catalysis A, General, ISSN 0926-860X, 2009, Volume 356, Issue 1, pp. 57 - 63
Basic properties of rare earth oxides were measured by CO desorption. The crystal structure varies with the ionic radius and with the valence of rare earth... 
Rare earth oxide | Lanthanide contraction | Basic property | Phase transition | SURFACE-STRUCTURE | CHEMISTRY, PHYSICAL | 1,4-BUTANEDIOL | 3-BUTEN-1-OL | ALCOHOLS | ENVIRONMENTAL SCIENCES | METHANE | DEHYDRATION | 1,3-BUTANEDIOL | CEO2 | CATALYSTS | ACIDITY | Rare earth metals | Analysis | Atmospheric nucleation | Crystals | Oxides | Universities and colleges | Structure
Journal Article
Gastric Cancer, ISSN 1436-3291, 1/2016, Volume 19, Issue 1, pp. 85 - 97
Journal Article
Journal Article
Journal Article